| Phase 13 trials |
|
Phase 1
|
NCT05507294 |
Mar → May 2021 |
— |
Haihe Biopharma Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT03457532 |
Dec 2017 → Sep 2023 |
neoplasm |
Haihe Biopharma Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT03466268 |
Sep 2017 → Jan 2023 |
neoplasm |
Haihe Biopharma Co., Ltd. |
Completed
|
No outcome recorded
|
| Phase 1/24 trials |
|
Phase 1/2
|
NCT06980532 |
Apr 2025 → Dec 2028 expected |
colorectal cancer |
Liu Huang |
Recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT04797702 |
Apr 2021 → Jul 2023 |
non-small cell lung carcinoma |
Shanghai Junshi Bioscience Co., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 1/2
|
NCT04338243 |
Nov 2019 → Dec 2020 |
— |
Haihe Biopharma Co., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 1/2
|
NCT04270591 |
Jul 2019 → Oct 2023 overdue |
— |
Haihe Biopharma Co., Ltd. |
Recruiting
|
No outcome recorded
|
| Phase 23 trials |
|
Phase 2
|
NCT06947291 |
Jun 2025 → Apr 2027 expected |
cancer |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06525350 |
Jul 2024 → Dec 2026 expected |
non-small cell lung carcinoma |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06452433 |
Jun 2024 → Dec 2027 expected |
non-small cell lung carcinoma |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Not yet recruiting
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT06908772 |
Apr 2025 → Dec 2028 expected |
— |
Shanghai JMT-Bio Inc. |
Not yet recruiting
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT06829459 |
Apr 2025 → Feb 2028 expected |
non-small cell lung carcinoma |
Shanghai JMT-Bio Inc. |
Recruiting
|
No outcome recorded
|